{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T23:55:29Z","timestamp":1780358129902,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.antiviral.2014.05.004","type":"journal-article","created":{"date-parts":[[2014,5,14]],"date-time":"2014-05-14T08:01:26Z","timestamp":1400054486000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Protection against Chikungunya virus induced arthralgia following prophylactic treatment with adenovirus vectored interferon (mDEF201)"],"prefix":"10.1016","volume":"108","author":[{"given":"Ashley","family":"Dagley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Ennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry A.","family":"Rood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud J.","family":"Van Wettere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian B.","family":"Gowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin G.","family":"Julander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2014.05.004_b0005","doi-asserted-by":"crossref","first-page":"8172","DOI":"10.1128\/JVI.00621-10","article-title":"Identification of wild-derived inbred mouse strains highly susceptible to monkeypox virus infection for use as small animal models","volume":"84","author":"Americo","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.05.004_b0010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/rmv.606","article-title":"Chikungunya and the nervous system: what we do and do not know","volume":"19","author":"Arpino","year":"2009","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2014.05.004_b0015","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.4269\/ajtmh.2010.10-0290","article-title":"Comparative pathogenesis of epidemic and enzootic Chikungunya viruses in a pregnant Rhesus macaque model","volume":"83","author":"Chen","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2014.05.004_b0020","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1186\/ar3683","article-title":"A 4-trifluoromethyl analogue of celecoxib inhibits arthritis by suppressing innate immune cell activation","volume":"14","author":"Chiba","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.antiviral.2014.05.004_b0025","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S1995-7645(13)60108-X","article-title":"Cytokine levels in patients with Chikungunya virus infection","volume":"6","author":"Chirathaworn","year":"2013","journal-title":"Asian Pac. J. Trop. Med."},{"key":"10.1016\/j.antiviral.2014.05.004_b0030","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.micinf.2009.09.002","article-title":"Focus on Chikungunya pathophysiology in human and animal models","volume":"11","author":"Couderc","year":"2009","journal-title":"Microbes Infect."},{"key":"10.1016\/j.antiviral.2014.05.004_b0035","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1371\/journal.ppat.0040029","article-title":"A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease","volume":"4","author":"Couderc","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2014.05.004_b0040","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1093\/rheumatology\/kes015","article-title":"Impaired quality of life after Chikungunya virus infection: a 2-year follow-up study","volume":"51","author":"Couturier","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.antiviral.2014.05.004_b0045","doi-asserted-by":"crossref","first-page":"e1446","DOI":"10.1371\/journal.pntd.0001446","article-title":"Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia","volume":"6","author":"Dupuis-Maguiraga","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.antiviral.2014.05.004_b0050","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1017\/S0950268808001167","article-title":"Atypical Chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005\u20132006 outbreak on Reunion","volume":"137","author":"Economopoulou","year":"2009","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.antiviral.2014.05.004_b0055","doi-asserted-by":"crossref","first-page":"R43","DOI":"10.1186\/ar2651","article-title":"Oral phosphatidylcholine pretreatment alleviates the signs of experimental rheumatoid arthritis","volume":"11","author":"Eros","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.antiviral.2014.05.004_b0060","doi-asserted-by":"crossref","first-page":"10877","DOI":"10.1128\/JVI.00949-10","article-title":"Chikungunya virus nonstructural protein 2 inhibits type I\/II interferon-stimulated JAK\u2013STAT signaling","volume":"84","author":"Fros","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.05.004_b0065","doi-asserted-by":"crossref","first-page":"8021","DOI":"10.1128\/JVI.02603-09","article-title":"Chikungunya virus arthritis in adult wild-type mice","volume":"84","author":"Gardner","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.05.004_b0070","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1371\/journal.pmed.0050060","article-title":"Multidisciplinary prospective study of mother-to-child Chikungunya virus infections on the island of La Reunion","volume":"5","author":"Gerardin","year":"2008","journal-title":"PLoS Med."},{"key":"10.1016\/j.antiviral.2014.05.004_b0075","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.4049\/jimmunol.176.6.3315","article-title":"Cutting edge: the direct action of type I IFN on CD4 T cells is critical for sustaining clonal expansion in response to a viral but not a bacterial infection","volume":"176","author":"Havenar-Daughton","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2014.05.004_b0080","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1172\/JCI42392","article-title":"A nonhuman primate model of Chikungunya disease","volume":"120","author":"Higgs","year":"2010","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.antiviral.2014.05.004_b0085","first-page":"86","article-title":"[Physiopathology of chronic arthritis following Chikungunya infection in man]","volume":"72 Spec No","author":"Jaffar-Bandjee","year":"2012","journal-title":"Med. Trop."},{"key":"10.1016\/j.antiviral.2014.05.004_b0090","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1128\/AAC.01635-10","article-title":"Treatment of yellow fever virus with an adenovirus-vectored interferon, DEF201, in a hamster model","volume":"55","author":"Julander","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2014.05.004_b0095","first-page":"231","article-title":"Chikungunya viral arthropathy: a clinical description","volume":"7","author":"Kennedy","year":"1980","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.antiviral.2014.05.004_b0100","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1172\/JCI40104","article-title":"Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages","volume":"120","author":"Labadie","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.antiviral.2014.05.004_b0105","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1348-0421.2011.00417.x","article-title":"High concentrations of circulating interleukin-6 and monocyte chemotactic protein-1 with low concentrations of interleukin-8 were associated with severe Chikungunya fever during the 2009\u20132010 outbreak in Thailand","volume":"56","author":"Lohachanakul","year":"2012","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2014.05.004_b0110","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ajpath.2010.11.018","article-title":"A mouse model of Chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis tenosynovitis myositis and persistence","volume":"178","author":"Morrison","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.antiviral.2014.05.004_b0115","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S8756-3282(02)00725-1","article-title":"Stage-dependent changes in trabecular bone turnover and osteogenic capacity of marrow cells during development of type II collagen-induced arthritis in mice","volume":"30","author":"Nishida","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.antiviral.2014.05.004_b0120","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1016\/j.vaccine.2011.01.076","article-title":"Probing the attenuation and protective efficacy of a candidate Chikungunya virus vaccine in mice with compromised interferon (IFN) signaling","volume":"29","author":"Partidos","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2014.05.004_b0125","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/INF.0b013e3180616d4f","article-title":"Mother-to-child transmission of Chikungunya virus infection","volume":"26","author":"Ramful","year":"2007","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.antiviral.2014.05.004_b0130","first-page":"493","article-title":"A simple method of estimating fifty percent endpoint","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hyg."},{"key":"10.1016\/j.antiviral.2014.05.004_b0135","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1177\/0883073808314151","article-title":"Neurologic manifestations of pediatric Chikungunya infection","volume":"23","author":"Robin","year":"2008","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.antiviral.2014.05.004_b0140","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1084\/jem.20090851","article-title":"Type I IFN controls Chikungunya virus via its action on nonhematopoietic cells","volume":"207","author":"Schilte","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2014.05.004_b0145","first-page":"681","article-title":"Viruses acquired abroad: what does the primary care physician need to know?","volume":"109","author":"Schmidt-Chanasit","year":"2012","journal-title":"Dtsch. Arztebl. Int."},{"key":"10.1016\/j.antiviral.2014.05.004_b0150","doi-asserted-by":"crossref","first-page":"e389","DOI":"10.1371\/journal.pntd.0000389","article-title":"Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period","volume":"3","author":"Sissoko","year":"2009","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.antiviral.2014.05.004_b0155","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.pharmthera.2009.09.005","article-title":"The immunobiology of viral arthritides","volume":"124","author":"Suhrbier","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.antiviral.2014.05.004_b0160","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.antiviral.2013.06.009","article-title":"Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy","volume":"99","author":"Thiberville","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.05.004_b0165","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1089\/vbz.2006.6.325","article-title":"Infectious clones of Chikungunya virus (La Reunion isolate) for vector competence studies","volume":"6","author":"Tsetsarkin","year":"2006","journal-title":"Vector Borne Zoonotic Dis."},{"key":"10.1016\/j.antiviral.2014.05.004_b0170","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1016\/j.vaccine.2011.01.108","article-title":"A complex adenovirus vaccine against Chikungunya virus provides complete protection against viraemia and arthritis","volume":"29","author":"Wang","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2014.05.004_b0175","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.virol.2007.07.024","article-title":"Pre- and post-exposure protection against Western equine encephalitis virus after single inoculation with adenovirus vector expressing interferon alpha","volume":"369","author":"Wu","year":"2007","journal-title":"Virology"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214001338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214001338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T05:55:47Z","timestamp":1538632547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354214001338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":35,"alternative-id":["S0166354214001338"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.05.004","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protection against Chikungunya virus induced arthralgia following prophylactic treatment with adenovirus vectored interferon (mDEF201)","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}